Faith Davies, MBBCh, MRCP, MD, FRCPath, is Professor of Medicine at the UAMS Myeloma Center and is an internationally-recognized expert in the treatment and research of multiple myeloma. Dr. Davies’ research focus includes innovative targeted molecular therapies, phase 1 clinical trials, and relapsed refractory disease.
Dr. Davies came to UAMS in 2014 from the Institute of Cancer Research and the Royal Marsden Hospital, both in London. She earned her medical degree from the College of Medicine, University of Wales. She completed general medical training in Cardiff and Birmingham and hematology specialty training in Leeds and London.
Dr. Davies’s focus is on the biology and treatment of myeloma with an emphasis on potential new drugs and new genetic technologies and their applications to myeloma. Her laboratory work is aimed at identifying biologically based therapeutic targets in myeloma that are amenable to small molecule interventions and translating those laboratory findings into individualized treatment in the clinical setting.
Dr. Davies is a member of the British Society of Haematology, the American Society of Hematology, the American Association for Cancer Research, the Royal College of Physicians, UK, and the Royal College of Pathologists, UK.